Cytokinetics
CYTK | NASDAQ
$62.56
-$0.43 (-0.68%)
Nov 2, 2026, 1:42 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 70.96M | 105.82M | 88.04M | 87.21M | 85.74M | 19.22M | 18.47M | 3.22M | 3.13M | 3.75M | 7.53M | 7.82M | 9.95M | 98.05M | 94.59M | 148.23M | 151.15M | 65.03M | 70.43M | 21.55M | 57.8M | 58.55M |
Cost of Revenue | 10.66M | 10.22M | 107.67M | 198.43M | 280.37M | 357.68M | 339.41M | 330.76M | 328.68M | 332.27M | 330.12M | 320.17M | 300.37M | 274.3M | 240.81M | 209.29M | 195M | 174.31M | 159.94M | 145.66M | 121.43M | 106.77M |
Gross Profit | 60.3M | 95.6M | -19.63M | -111.22M | -194.63M | -338.46M | -320.93M | -327.54M | -325.54M | -328.52M | -322.59M | -312.35M | -290.42M | -176.25M | -146.23M | -61.06M | -43.84M | -109.28M | -89.51M | -124.11M | -63.63M | -48.22M |
Operating Income | -704.62M | -640.25M | -612.26M | -572.93M | -546.98M | -565.64M | -536.25M | -524.63M | -506.09M | -497.97M | -496.21M | -495.82M | -481.99M | -370.82M | -324.2M | -218.88M | -179.64M | -223.56M | -186.31M | -201.02M | -126.63M | -104.19M |
Interest Income | 46.68M | 45.74M | 48.42M | 51.96M | 58.77M | 57.32M | 51.53M | 44.11M | 33.89M | 29.12M | 27.63M | 25.96M | 23.27M | 17.35M | 11.34M | 5.42M | 1.51M | 833K | 708K | 2.85M | 3.7M | 4.9M |
Pretax Income | -894M | -829.61M | -784.96M | -751.94M | -606.31M | -615.26M | -589.53M | -576.4M | -545.28M | -530.6M | -526.24M | -526.73M | -539.62M | -430.8M | -388.96M | -282.15M | -215.92M | -257.66M | -215.31M | -228.67M | -155.76M | -134.99M |
Net Income | -894M | -829.61M | -784.96M | -751.94M | -606.31M | -615.26M | -589.53M | -576.4M | -545.28M | -530.6M | -526.24M | -526.73M | -539.62M | -430.8M | -388.96M | -282.15M | -215.92M | -257.66M | -215.31M | -228.67M | -155.76M | -134.99M |
Selling & General & Admin | 370.47M | 331.8M | 284.27M | 254.89M | 242.08M | 227.18M | 215.31M | 197.09M | 180.55M | 169.45M | 173.61M | 183.47M | 191.58M | 194.57M | 177.98M | 157.81M | 135.79M | 114.28M | 96.8M | 76.91M | 63.01M | 55.97M |
Research & Development | 394.1M | 408.85M | 413.17M | 405.26M | 390.64M | 357.68M | 339.41M | 330.76M | 328.68M | 332.27M | 330.12M | 320.17M | 300.37M | 274.3M | 240.81M | 209.29M | 195M | 174.31M | 159.94M | 145.66M | 121.43M | 106.77M |
Other Expenses | 342K | -4.8M | -104.81M | -198.43M | -280.37M | -357.68M | -339.41M | -330.76M | -328.68M | -332.27M | -330.12M | -320.17M | -300.37M | -274.3M | -240.81M | -209.29M | -195M | -174.31M | -159.94M | -145.66M | -121.43M | -106.77M |
Operating Expenses | 764.92M | 735.84M | 592.63M | 461.71M | 352.35M | 227.18M | 215.31M | 197.09M | 180.55M | 169.45M | 173.61M | 183.47M | 191.58M | 194.57M | 177.98M | 157.81M | 135.79M | 114.28M | 96.8M | 76.91M | 63.01M | 55.97M |
Interest Expense | 124.82M | 114.26M | 103.87M | 96.13M | 92.1M | 92.14M | 86.51M | 80.98M | 72.68M | 61.75M | 57.67M | 56.87M | 58.64M | 55.09M | 51.16M | 43.75M | 35.1M | 32.24M | 29.71M | 30.51M | 32.83M | 35.69M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 775.58M | 746.06M | 700.3M | 660.14M | 632.72M | 584.86M | 554.72M | 527.85M | 509.22M | 501.72M | 503.74M | 503.63M | 491.95M | 468.87M | 418.79M | 367.11M | 330.79M | 288.59M | 256.74M | 222.57M | 184.43M | 162.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 132.09M | 123.27M | 122.02M | 119.98M | 119.46M | 118.5M | 118.08M | 117.69M | 109.24M | 101.92M | 99.07M | 96.07M | 95.76M | 95.16M | 94.68M | 93.76M | 85.73M | 85M | 83.86M | 80.09M | 71.75M | 71.2M |
Shares Outstanding (Diluted) | 132.09M | 123.27M | 122.43M | 119.98M | 119.46M | 118.5M | 118.08M | 117.69M | 109.24M | 101.92M | 99.07M | 96.07M | 95.76M | 95.16M | 94.68M | 93.76M | 85.73M | 85M | 84.09M | 80.33M | 71.75M | 71.2M |
EPS (Basic) | -7.21 | -6.83 | -6.52 | -6.30 | -5.11 | -5.30 | -5.27 | -5.38 | -5.37 | -5.40 | -5.43 | -5.44 | -5.97 | -4.97 | -4.80 | -3.77 | -2.84 | -3.36 | -2.83 | -3.09 | -2.19 | -2.01 |
EPS (Diluted) | -7.22 | -6.84 | -6.53 | -6.30 | -5.11 | -5.30 | -5.27 | -5.38 | -5.37 | -5.40 | -5.43 | -5.44 | -5.97 | -4.97 | -4.80 | -3.77 | -2.84 | -3.36 | -2.83 | -3.09 | -2.19 | -2.01 |
EBITDA | -818.6M | -734.67M | -701.48M | -646.17M | -504.83M | -513.62M | -493.48M | -481.94M | -459.67M | -455.54M | -454.81M | -459.69M | -470.57M | -366.1M | -329.4M | -230.42M | -174.48M | -220.54M | -181.75M | -196.15M | -121.92M | -98.41M |
EBIT | -834.35M | -745.69M | -711.42M | -655.82M | -514.21M | -523.12M | -503.01M | -495.42M | -472.6M | -468.85M | -468.58M | -469.86M | -480.97M | -375.71M | -337.8M | -238.77M | -181.2M | -225.8M | -185.98M | -198.16M | -124.01M | -100.37M |
Depreciation & Amortization | 15.75M | 11.02M | 9.94M | 9.65M | 9.38M | 9.5M | 9.53M | 13.48M | 12.93M | 13.31M | 13.76M | 10.17M | 10.4M | 9.61M | 8.4M | 8.35M | 6.72M | 5.26M | 4.23M | 2.01M | 2.09M | 1.96M |
Add to Watchlist
Select watchlists to add or remove CYTK